Patients travel easily with oral sprays, do not need to dispose of biohazardous sharps, and maintain high compliance over months or years
Bloating appears at days three to ten after a dose escalation and peaks in weeks two to three
Glucagon-like peptide-1 receptor agonists (GLP-1RAs), including exenatide, liraglutide, and semaglutide, have shown promise in reducing body weight, improving glycemic control, and slowing the progression of cardiovascular and kidney diseases
What it actually does May improve gut permeability at a high dose (~30g/day)
If there is no itching, scaling, or burning associated with these spots, they could be signs of Vitiligo
[8] Timms et al